You searched for "outcome"
Pseudophakic Monovision: A Clinical Guide
The contents of this small volume should provide useful tips for all ophthalmic practitioners involved with managing patients undergoing cataract surgery. For those ophthalmic clinicians and supporting staff not familiar with the potential options for achieving a spectacle independent refractive...
Does intravitreal bevacizumab help in diabetic retinopathy related vitreous haemorrhage?
This retrospective, interventional case series, aimed to assess the effectiveness of intravitreal bevacizumab (IVB) in vitreous haemorrhage secondary to proliferative diabetic retinopathy. The primary outcome was the rate of vitrectomy (PPV) after IVB, with secondary outcomes the number of IVB...
Clinical evaluation of a new pupil independent diffractive MIOL lens with a ±2.75D near addition
This is a clinical outcome assessment after cataract surgery with implantation of multifocal intraocular lens implant IOL with a lower near addition (+2.75D) of 143 eyes of 85 patients aged between 40 to 83 years of age. The type of...
Intravitreal Bevacizumab for the prevention of postoperative proliferative vitreoretinopathy in high-risk patients
This single- centre observational retrospective study was conducted to evaluate the effect of intravitreal injection of bevacizumab at the time surgery for rhegmatogenous retinal detachment (RRD) repair on postoperative proliferative vitreoretinopathy (PVR) in patients at high risk selected by laser...
Verteporfin shortage: treatment options and outcomes in chronic non-resolving central serous chorioretinopathy
Half-dose photodynamic therapy (HD-PDT) with verteporfin has been the therapy of choice in non-resolving central serous chorioretinopathy lasting longer than four months. Since 2021, a worldwide shortage of verteporfin due to manufacturing issues prompted adjustments in treatment practices. This retrospective,...
Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report
Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...Learnings and trends in the management of open-angle and angle-closure glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...OpenEyes – Community edition
Moving to an electronic patient record (EPR) is all the rage these days, even in the District General Hospitals (DGHs). When I am not writing these articles I work in one such hospital. At Bolton Foundation Trust we deployed OpenEyes...
